Loading...
XSHE
000999
Market cap5.81bUSD
Jun 06, Last price  
32.69CNY
1D
-24.40%
1Q
-21.47%
Jan 2017
32.19%
IPO
61.03%
Name

China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
P/E
12.39
P/S
1.51
EPS
2.64
Div Yield, %
4.59%
Shrs. gr., 5y
5.52%
Rev. gr., 5y
13.44%
Revenues
27.62b
+11.63%
2,969,474,2782,867,926,0713,397,843,5874,316,186,8844,852,717,0394,365,153,3155,525,222,9366,891,102,6327,801,603,7477,276,585,5717,900,189,5638,981,721,08011,119,916,37913,427,746,16214,701,918,76313,637,258,15315,319,993,63418,079,461,48224,738,963,31927,616,611,772
Net income
3.37b
+18.05%
119,934,235164,922,481279,797,200500,086,807709,489,009815,984,768760,447,5661,014,076,1211,181,104,7641,035,889,0141,249,226,5351,197,840,5991,301,687,2491,432,078,2012,112,494,7681,597,489,1752,055,104,4072,448,802,1032,852,931,6643,367,888,968
CFO
4.40b
+4.31%
22,825,379425,505,881605,297,1941,116,375,222855,051,790848,277,111954,901,8951,211,832,6161,467,423,8251,184,427,7221,259,838,1831,392,140,6771,560,392,8231,911,246,8171,971,829,7662,223,984,7051,870,515,9683,006,375,0164,220,402,0634,402,199,387
Dividend
Jun 14, 20241.5 CNY/sh

Profile

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.
URL
https://www.999.com.cn/
IPO date
Mar 09, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
27,616,612
11.63%
24,738,963
36.83%
18,079,461
18.01%
Cost of revenue
20,364,062
18,517,953
14,237,691
Unusual Expense (Income)
NOPBT
7,252,550
6,221,011
3,841,771
NOPBT Margin
26.26%
25.15%
21.25%
Operating Taxes
815,869
580,975
466,425
Tax Rate
11.25%
9.34%
12.14%
NOPAT
6,436,680
5,640,036
3,375,345
Net income
3,367,889
18.05%
2,852,932
16.50%
2,448,802
19.16%
Dividends
(1,055,918)
(841,854)
Dividend yield
1.66%
1.84%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
855,567
885,651
235,092
Long-term debt
361,836
2,041,955
261,859
Deferred revenue
449,161
455,501
423,190
Other long-term liabilities
157,993
676,377
119,688
Net debt
(4,552,743)
(6,024,120)
(5,600,854)
Cash flow
Cash from operating activities
4,402,199
4,220,402
3,006,375
CAPEX
(857,211)
Cash from investing activities
(821,735)
Cash from financing activities
450,425
FCF
5,852,625
1,639,863
2,918,724
Balance
Cash
6,694,167
8,226,787
3,149,709
Long term investments
(924,020)
724,938
2,948,096
Excess cash
4,389,317
7,714,777
5,193,832
Stockholders' equity
22,758,594
21,908,937
15,946,697
Invested Capital
22,599,606
20,031,567
12,755,444
ROIC
30.20%
34.40%
26.67%
ROCE
26.53%
22.15%
21.15%
EV
Common stock shares outstanding
1,280,566
1,278,900
978,900
Price
44.34
-10.84%
49.73
6.24%
46.81
36.71%
Market cap
56,780,303
-10.72%
63,599,717
38.80%
45,822,309
36.71%
EV
57,580,762
62,870,329
40,745,236
EBITDA
8,090,750
7,017,678
4,364,512
EV/EBITDA
7.12
8.96
9.34
Interest
80,038
85,174
21,227
Interest/NOPBT
1.10%
1.37%
0.55%